JAMA 9 2026 Adoption of Adjunctive Azithromycin for Unscheduled Cesarean Delivery and Postpartum Infections

This research study examines how clinical practices evolved following a 2016 discovery that adding the antibiotic azithromycin to standard care significantly lowers the risk of postpartum infections for those undergoing unplanned cesarean sections. By analyzing over a decade of health data, the authors found a substantial increase in the administration of this medication during surgical births in the years following the trial's publication. This shift in medical protocol successfully correlated with a meaningful decline in infection rates among new parents, proving that the medical community effectively translated scientific evidence into improved patient outcomes. Ultimately, the text serves as a testament to how evidence-based medicine can be rapidly adopted to make the nation's most common surgery safer.